TNF alpha production inhibitors (Procter & Gamble)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTNF alpha production inhibitors (Procter & Gamble)
Drug Alias Nametumor necrosis factor alpha production inhibitors (Procter & Gamble)PG-706019PG-706840PG-714936PG-714957 +[26] 
ClassificationSmall molecules
Mechanisms of ActionTNF alpha synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel DiseasesOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A